Suchergebnisse - "Kurti, Zsuzsanna"

PubPharm (7)

1

Benefits of implementing a rapid access clinic in a high-volume inflammatory bowel disease center : Access, resource utilization and outcomes

enthalten in: World journal of gastroenterology | 2020

von Nene, S. | Gonczi, L. | Kurti, Z. | +11

2

Outcomes of Patients With Inflammatory Bowel Diseases Switched From Maintenance Therapy With a Biosimilar to Remicade

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2019

von Ilias, A. | Szanto, K. | Gonczi, L. | +10

3

Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis - results from multicenter observational cohort

enthalten in: Expert opinion on biological therapy | 2018

von Bálint, A. | Rutka, M. | Kolar, M. | +23

4

Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort

enthalten in: Inflammatory bowel diseases | 2017

von Gonczi, L. | Gecse, K. | Vegh, Z. | +23

5

Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases : results from Central European nationwide cohort

enthalten in: Expert opinion on drug safety | 2017

von Bálint, A. | Rutka, M. | Végh, Z. | +30

6

Prediction of Short- and Medium-term Efficacy of Biosimilar Infliximab Therapy. Do Trough Levels and Antidrug Antibody Levels or Clinical And Biochemical Markers Play the More Important Role?

enthalten in: Journal of Crohn's & colitis | 2017

von Gonczi, L. | Vegh, Z. | Golovics, P. | +22

7

Prevalence and predictors of hospitalization in Crohn's disease in a prospective population-based inception cohort from 2000-2012

enthalten in: World journal of gastroenterology | 2015

von Golovics, P. | Lakatos, L. | Mandel, M. | +7

1
[1]